stavudine has been researched along with Disease Exacerbation in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (45.83) | 18.2507 |
2000's | 10 (41.67) | 29.6817 |
2010's | 3 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bekker, LG; Gupta-Wright, A; Lawn, SD; Wood, R | 1 |
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB | 1 |
Allcock, RJ; Black, M; Cherry, CL; Goullee, H; Kamerman, PR; Price, P; Wadley, AL | 1 |
Bassetti, D; Bassetti, M; Ciravegna, BW; Di Biagio, A; Ferrazin, A; Rosso, R | 1 |
Katano, H; Kimura, S; Niino, H; Oka, S; Teruya, K; Yamamoto, Y; Yasuoka, A | 1 |
Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
Gonzalez, RG; Hedreen, JC; Lipton, SA; Monti, L; Navia, BA; Rostasy, K | 1 |
Bekker, V; Jurriaans, S; Kuijpers, TW; Lange, JM; Scherpbier, HJ; van Leth, F | 1 |
Barberá Farré, JR; Beato Pérez, JL; Cuadra García-Tenorio, F; Geijo Martínez, MP; Maciá Martínez, MA; Marcos Sánchez, F; Martínez Alfaro, E; Moreno Mendaña, JM; Rodríguez Zapata, M; Sanz Moreno, J; Sanz Sanz, J; Solera Santos, J | 1 |
Asboe, D; Babiker, AG; Darbyshire, JH; Goodall, RL; Hooker, MH; Williams, IG | 1 |
Ananworanich, J; Bunupuradah, T; Leng, LK; Pancharoen, C; Sosothikul, D; Thisyakorn, U; Trinavarat, P | 1 |
Church, JA; Dunkle, LM; Federici, ME; Goldsmith, JC; Harris, AT; Kaul, S; Kline, MW; Loewen, DF; Schultze, ME; Woods, L | 1 |
Cross, A; Dellamonica, P; Dunkle, L; Gathe, J; Jemsek, JG; Mellors, JW; Murphy, R; Pavia, AT; Spruance, SL; Stool, E | 1 |
Brizzi, M; Ceccherini-Nelli, L; Forastieri, G; Iuliano, R; Mazzotta, F; Mecocci, L | 1 |
Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE | 1 |
Culnane, M; Gwynne, M; Hutcheon, N; Kline, MW; Lindsey, JC; McKinney, RE; Mitchell, WG; Nichols, S; Van Dyke, RB; Yogev, R | 1 |
Barton, S; Blaxhult, A; Clotet, B; Goebel, FD; Hirschel, B; Katlama, C; Lundgren, JD; Pedersen, C; Phillips, AN; Vella, S | 1 |
Cammack, N; Dalgleish, AG; Sharland, M; Watkins, AM; Westby, M | 1 |
Auger, S; Besnier, JM; Billaud, E; Billaudel, S; Chennebault, JM; Lafeuillade, A; May, T; Michelet, C; Perre, P; Raffi, F; Reliquet, V | 1 |
Flepp, M; Jost, J; Ledergerber, B; Opravil, M; Paris, D; Ruef, C; Weber, R; Zimmerli, S | 1 |
Carter, LM; Ellis, BA; Peters, BS; Wolstencroft, RA | 1 |
Gilden, D | 1 |
Antinori, A; Bruno, R; Bugarini, R; Chigiotti, S; Chirianni, A; De Luca, A; De Stefano, C; Gritti, F; Monforte, Ade A; Moroni, M; Mussini, C; Perrella, O; Pezzotti, P; Piazza, M; Pizzigallo, E; Tirelli, U; Vigevani, GM | 1 |
7 trial(s) available for stavudine and Disease Exacerbation
Article | Year |
---|---|
[Clinical trial comparing efficacy and safety of four highly active antiretroviral therapy (HAART) in antiretroviral-naive treatment with advanced HIV infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Ritonavir; Stavudine; Zidovudine | 2006 |
A virological benefit from an induction/maintenance strategy: the Forte trial.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Patient Compliance; Remission Induction; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Time Factors; Treatment Failure; United Kingdom; Viral Load | 2007 |
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Female; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Stavudine; Survival Rate; Zidovudine | 1995 |
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Nausea; Neutropenia; Stavudine; Vomiting; Zidovudine | 1997 |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1997 |
A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.
Topics: Anti-HIV Agents; Bias; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Male; Neutropenia; Stavudine; Zidovudine | 1998 |
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine; Viral Load | 1998 |
17 other study(ies) available for stavudine and Disease Exacerbation
Article | Year |
---|---|
Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Lamivudine; Male; Medication Adherence; Nevirapine; Risk Factors; South Africa; Stavudine; Time Factors; Tuberculosis; Viral Load | 2013 |
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.
Topics: Adult; Anti-HIV Agents; Black People; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cohort Studies; Disease Progression; Female; Gene Expression; Haplotypes; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Polyneuropathies; Prognosis; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; South Africa; Stavudine | 2016 |
Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection.
Topics: Acidosis, Lactic; Adenine; Adolescent; Antiretroviral Therapy, Highly Active; Carbamates; Diagnosis, Differential; Didanosine; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Furans; Guillain-Barre Syndrome; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Organophosphonates; Organophosphorus Compounds; Risk Assessment; Severity of Illness Index; Stavudine; Sulfonamides; Tenofovir | 2003 |
Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS--associated Kaposi sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Disease Progression; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Gastrointestinal Neoplasms; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV-1; Humans; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Prednisone; Ritonavir; Saquinavir; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Tumor Virus Infections; Vincristine | 2003 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
HIV leucoencephalopathy and TNFalpha expression in neurones.
Topics: Adult; AIDS Dementia Complex; Anti-Retroviral Agents; Basal Ganglia; Biopsy; Brain; Diffusion Magnetic Resonance Imaging; Disease Progression; Follow-Up Studies; Frontal Lobe; HIV Envelope Protein gp41; Humans; Macrophages; Male; Microglia; Middle Aged; Neurologic Examination; Neurons; Neuropsychological Tests; Saquinavir; Stavudine; Treatment Outcome; Tumor Necrosis Factor-alpha; Zidovudine | 2005 |
Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Nelfinavir; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure | 2006 |
Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cervical Vertebrae; Child; Disease Progression; Female; HIV Infections; Humans; Lamivudine; Nevirapine; Remission, Spontaneous; Spinal Neoplasms; Stavudine; Time Factors | 2007 |
Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
Topics: Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; RNA, Viral; Stavudine; Viral Load; Viremia; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Dideoxynucleosides; Disease Progression; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Stavudine; Survival Analysis; Zalcitabine; Zidovudine | 1998 |
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral Therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Disease Progression; Female; Follow-Up Studies; Humans; Immunity, Cellular; Immunologic Memory; Lamivudine; Lymphocyte Count; Nelfinavir; Stavudine; Viral Load | 1998 |
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Disease Progression; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; RNA, Viral; Salvage Therapy; Saquinavir; Stavudine; Switzerland; Treatment Failure; Viral Load; Zalcitabine; Zidovudine | 1999 |
Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Lymphocytes; Macrophage Inflammatory Proteins; Male; Nelfinavir; Stavudine; Viral Load; Viremia | 2000 |
Study shows three drugs better than two.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Stavudine; United States; Zidovudine | 1997 |
Spring cleaning in trial land.
Topics: Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Stavudine; United States; Viral Load; Zidovudine | 1997 |
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
Topics: Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Disease Progression; Female; Hepatitis B Surface Antigens; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Male; Proportional Hazards Models; Stavudine; Zidovudine | 2001 |